| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 31.50B | 38.66B | 31.96B | 34.16B | 33.14B | 27.16B |
| Gross Profit | 7.77B | 9.06B | 7.60B | 9.03B | 8.39B | 6.21B |
| EBITDA | 6.59B | 7.79B | 6.29B | 7.83B | 7.32B | 5.28B |
| Net Income | 2.81B | 3.28B | 2.40B | 3.83B | 3.46B | 2.35B |
Balance Sheet | ||||||
| Total Assets | 56.83B | 65.86B | 59.52B | 51.11B | 46.89B | 43.52B |
| Cash, Cash Equivalents and Short-Term Investments | 3.52B | 3.60B | 3.65B | 3.25B | 3.68B | 3.79B |
| Total Debt | 21.18B | 29.16B | 23.02B | 18.52B | 18.55B | 20.55B |
| Total Liabilities | 35.74B | 41.03B | 37.70B | 31.46B | 30.82B | 30.73B |
| Stockholders Equity | 21.10B | 24.83B | 21.82B | 19.64B | 16.06B | 12.79B |
Cash Flow | ||||||
| Free Cash Flow | 5.77B | -4.12B | -3.02B | -29.69M | 2.39B | -1.27B |
| Operating Cash Flow | 5.77B | 6.79B | 4.57B | 3.66B | 5.81B | 4.42B |
| Investing Cash Flow | 0.00 | -11.97B | -7.59B | -3.27B | -3.42B | -5.69B |
| Financing Cash Flow | 0.00 | 5.19B | 3.60B | -406.16M | -2.56B | 1.47B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥204.68B | 16.43 | 4.41% | 3.80% | -1.50% | -32.46% | |
68 Neutral | ¥868.55B | 25.35 | 4.79% | 4.21% | -1.21% | -27.21% | |
65 Neutral | ¥91.59B | 35.93 | ― | 0.67% | 10.18% | -14.36% | |
65 Neutral | ¥932.85B | 9.58 | 8.79% | 2.68% | -1.64% | ― | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | ¥317.04B | -33.94 | -4.00% | 3.71% | 0.24% | -234.36% | |
60 Neutral | ¥566.51B | 78.15 | 1.08% | 3.37% | -1.94% | -84.08% |